Figure - PMC

Skip to main content

An official website of the United States government

Here's how you know

Here's how you know

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

View full-text article in PMC

. 2024 Jun 20;16(6):992. doi: 10.3390/v16060992

Search in PMC
Search in PubMed
View in NLM Catalog
Add to search

© 2024 by the authors.

Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).

PMC Copyright notice

Timeline with relevant data from the clinical history of the patient, which resulted anti-HD positive. The upper part of the figure depicts data with respect to HIV-RNA (blue line) and HCV-RNA (orange line) trends; the purple asterisks represent the serialized controls of virological tests for HBV (HBV-DNA and complete serology, which were always completely negative). The lower part of the figure depicts the treatment regimens she underwent for both HIV (in green) and HCV (in orange) infections. The arrow refers to the time when the patient was sampled for the present study (April 2023), as reported in Table 1. Abbreviations: abacavir (ABC); atazanavir (ATV); cobicistat (COBI); darunavir (DRV); dolutegravir (DTG); emtricitabine (FTC); hepatitis B virus (HBV); hepatitis C virus (HCV); human immunodeficiency virus (HIV); lamivudine (3TC); nevirapine (NVP); pegylated interferon (PEG-IFN); ribavirin (RBV); ritonavir (RTV); sofosbuvir (SOF); tenofovir disoproxil fumarate (TDF); velpatasvir (VEL); zidovudine (ZDV).